SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Jean-Jacques Rousseau

PatientJean-Jacques Rousseau
Date of birth1971-06-28
IdentifiersMRN HR-EN003-SYN; SSN (made up) 000-03-2716
Document date2026-04-21
AuthorCelestine Marchetti-Owusu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review four weeks after urethroplasty; wants to try the medicine for sleep and worry. [S]

History of Present Illness

Mr. Rousseau returns four weeks after an excision and primary anastomosis bulbar urethroplasty. The pathology showed dense fibrosis of the corpus spongiosum without inflammation or malignancy. The catheter came out a week ago after a urethrogram around it showed no leak. He now passes urine with what he calls a stream he has not had since childhood, empties fully, and gets up once at night. The perineal wound is healed; he takes acetaminophen once a day at most. He has had seven sessions of CBT for psychosis. He says the beliefs still weigh on him at night and he sleeps about five hours, and that, now his bladder no longer wakes him, he wants to see whether the medicine he was offered helps his sleep and worry. He has had no thoughts of suicide or of harming anyone. [S]

ElementDetail
SurgeryAnastomotic bulbar urethroplasty four weeks ago; catheter out a week ago with no leak
VoidingFree stream; up once at night
PsychotherapySeven CBT sessions
Medication decisionAsks to start aripiprazole
SafetyNo thoughts of suicide or of harming anyone

Review of Systems

SystemResultFinding
GenitourinaryNegativeStrong stream, empties fully, no burning, no blood; erections unchanged
IntegumentaryNegativePerineal wound healed
NeurologicalNegativeNo tremor, stiffness, restlessness, or abnormal movements
PsychiatricPositivePersecutory beliefs and night-time worry; no hallucinations; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route2026-03-24activeS
Aripiprazole 5 mg oral tablet, one tablet by mouth each morningOne tablet each morningOral route2026-04-21activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-21Body height166cmS
2026-04-21Body weight63.2kgS
2026-04-21Body mass index (BMI) [Ratio]22.9kg/m2S
2026-04-21Systolic blood pressure124mm[Hg]S
2026-04-21Diastolic blood pressure78mm[Hg]S
2026-04-21Heart rate74/minS
2026-04-21Respiratory rate14/minS
2026-04-21Body temperature36.7CelS
2026-04-21Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-21Symptom score [AUASI]6{score}S
2026-04-21If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]2{score}S
2026-04-21Maximum Urine flow by Uroflowmetry21.5mL/sA maximum flow of 15 mL/s or more is normal for a voided volume above 150 mLNormalS
2026-04-21US Urinary bladder Volume post void25mL<=100 mLNormalS
2026-04-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-04-21Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-04-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M92mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-21Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-04-21Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-04-21Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=199 mg/dLNormalS
2026-04-21Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=40 mg/dLNormalS
2026-04-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation122mg/dL<=129 mg/dLNormalS
2026-04-21Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
2026-04-21Waist Circumference at umbilicus by Tape measure92cmBelow 102 cm for menNormalS

Physical Exam

Vital signs recorded on 2026-04-21; see the Vital Signs section. [S]

SystemFinding
GeneralWell and cheerful about his bladder
GenitourinaryPerineal incision healed; no swelling or tenderness; right inguinal hernia small and reducible
NeurologicalNo tremor, rigidity, or involuntary movements; AIMS total 0 at baseline
Mental statusCalm and courteous; mood "better by day, troubled at night"; persecutory beliefs unchanged in content; no hallucinations; no suicidal or violent ideation; capacity for the medication decision present

Problems

ProblemClinical statusVerificationCodeProvenance
Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under wayresolvedconfirmed R46.5S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed.
Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy bookedresolvedconfirmed R33.9S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed.
Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefsactiveconfirmed F22S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered.
Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retentionactiveconfirmed N35.812S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis.
Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urineactiveconfirmed K40.90S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveySuicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety planEvery visitCompleted todayNo thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed
SurveyPHQ-9 for depressive symptomsAt least monthlyCompleted today6; the psychologist recorded 6 and 7 at sessions in March and April
ReferralCognitive behavioral therapy for psychosisAbout 16 sessionsCompleted todaySeven sessions; continuing
Medication safetyAntipsychotic started by shared decision-makingWhen the patient chooses itCompleted todayAripiprazole 5 mg started at his request after benefits and risks were discussed
LaboratoryBaseline fasting glucose, hemoglobin A1c, and lipids before a second-generation antipsychoticBaseline, 12 weeks, then yearlyCompleted todayGlucose 92 mg/dL, A1c 5.4 percent, total cholesterol 196, HDL 48, LDL 122, triglycerides 130 mg/dL
ExaminationBaseline weight, BMI, waist, and blood pressureWeight at baseline, 4, 8, and 12 weeks; waist and blood pressure at baseline and 12 weeksCompleted today63.2 kg, BMI 22.9, waist 92 cm, 124/78 mmHg
ExaminationAIMS and akathisia checkAIMS at baseline and every 6 months; akathisia at each visitCompleted todayAIMS 0; no restlessness
SurveyIPSS and quality-of-life score after treatmentAfter treatment and at each surveillance visitCompleted todayIPSS 6; quality of life 2
ImagingUroflowmetry and post-void residual after urethroplastyAfter catheter removal, then at about 3, 6, and 12 monthsCompleted todayMaximum flow 21.5 mL/s; residual 25 mL
ImagingPericatheter urethrogram before catheter removalAbout three weeks after anastomotic urethroplastyUp to dateA week ago: no leak; catheter removed
LaboratoryCreatinine and eGFRAfter relief of obstruction, and before metformin, NSAIDs, or contrastCompleted today0.98 mg/dL; eGFR 92
ExaminationInguinal hernia checkAt each review while under watchful waitingCompleted todayUnchanged

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023); International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018)

Follow-up: Weight check in four weeks; review at twelve weeks on aripiprazole with fasting blood tests and a flow test; CBT continues. Next scheduled visit 2026-07-14: twelve-week aripiprazole and urethroplasty follow-up. [S]